China Health Ministry Cracks Down On Stem-Cell Trials
This article was originally published in PharmAsia News
Executive Summary
China’s medical institutions have been advised that a freeze on new stem-cell clinical trials was ordered until mid-year due to concerns that clinical trials are not in compliance with government regulations.